ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
Mar 2026
Jul 2025
Latest Journal Issues
Nuclear Science and Engineering
March 2026
Nuclear Technology
February 2026
Fusion Science and Technology
April 2026
Latest News
NRC approves TerraPower construction permit
Today, the Nuclear Regulatory Commission announced that it has approved TerraPower’s construction permit application for Kemmerer Unit 1, the company’s first deployment of Natrium, its flagship sodium fast reactor.
This approval is a significant milestone on three fronts. For TerraPower, it represents another step forward in demonstrating its technology. For the Department of Energy, it reflects progress (despite delays) for the Advanced Reactor Demonstration Program (ARDP). For the NRC, it is the first approval granted to a commercial reactor in nearly a decade—and the first approval of a commercial non–light water reactor in more than 40 years.
Martha Hultqvist, Irena Gudowska
Nuclear Technology | Volume 168 | Number 1 | October 2009 | Pages 123-127
Dose/Dose Rate | Special Issue on the 11th International Conference on Radiation Shielding and the 15th Topical Meeting of the Radiation Protection and Shielding Division (Part 1) / Radiation Protection | doi.org/10.13182/NT09-A9111
Articles are hosted by Taylor and Francis Online.
The mathematical anthropomorphic phantoms EVA-HIT and ADAM-HIT have been used in the Monte Carlo code SHIELD-HIT07 for simulations of lung tumor and prostate irradiation with light ions. Calculations were performed for 1H, 7Li, and 12C beams of energies in the range of 80 to 330 MeV/u. The secondary doses to organs, due to scattered primary ions and secondary particles produced in the phantoms, were studied taking into account the contribution from secondary neutrons, secondary protons, pions, and heavier fragments from helium to calcium. The doses to organs per dose to target (tumor) are of the order of 10-6 to 10-1 mGy Gy-1 and decrease with increasing distance from the target. In general the organ dose per target dose increases with increasing Z of the primary particle; however, for lighter primary ions (Z 3) and for organs close to the target, scattered primary particles show a nonnegligible dose contribution.